Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?
about
Modes of Antigen Presentation by Lymph Node Stromal Cells and Their Immunological ImplicationsAntitumor immune responses mediated by dendritic cells: How signals derived from dying cancer cells drive antigen cross-presentationSaponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formationHyperosmolarity impedes the cross-priming competence of dendritic cells in a TRIF-dependent manner.Harnessing Human Cross-Presenting CLEC9A(+)XCR1(+) Dendritic Cells for Immunotherapy.Chemotherapy enhances cross-presentation of nuclear tumor antigensEnterovirus-infected β-cells induce distinct response patterns in BDCA1+ and BDCA3+ human dendritic cells.Quantitating MHC class II trafficking in primary dendritic cells using imaging flow cytometryGeneration of a cord blood-derived Wilms Tumor 1 dendritic cell vaccine for AML patients treated with allogeneic cord blood transplantation.Plasmacytoid Dendritic Cells Require Direct Infection To Sustain the Pulmonary Influenza A Virus-Specific CD8 T Cell Response.Distinct Transcriptional Programs Control Cross-Priming in Classical and Monocyte-Derived Dendritic CellsEnhancement of anti-tumor CD8 immunity by IgG1-mediated targeting of Fc receptors.Engaging adaptive immunity with biomaterialsHuman plasmacytoid dendritic cells: from molecules to intercellular communication networkB-cell modulation of dendritic-cell function: signals from the far side.Therapeutic use of dendritic cells to promote the extranodal priming of anti-tumor immunity.The role of dendritic cells in graft-versus-tumor effectHuman dendritic cell functional specialization in steady-state and inflammation.Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy.Various ways to improve whole cancer cell vaccines.Understanding the biology of antigen cross-presentation for the design of vaccines against cancer.Differential uptake and cross-presentation of soluble and necrotic cell antigen by human DC subsets.The Biology and Underlying Mechanisms of Cross-Presentation of Exogenous Antigens on MHC-I Molecules.Distinct activation of primary human BDCA1(+) dendritic cells upon interaction with stressed or infected β cells.Comparative Immunogenicity of a Cytotoxic T Cell Epitope Delivered by Penetratin and TAT Cell Penetrating Peptides.A subset of human plasmacytoid dendritic cells expresses CD8α upon exposure to herpes simplex virus type 1.Cross-presentation of antigens by dendritic cells: role of autophagy.Migratory dendritic cells acquire and present lymphatic endothelial cell-archived antigens during lymph node contraction.Enhanced immune response induced by P5 HER2/neu-derived peptide-pulsed dendritic cells as a preventive cancer vaccine.Strong in vivo antitumor responses induced by an antigen immobilized in nanogels via reducible bonds.Modulation of Immune Checkpoints and Graft-versus-Leukemia in Allogeneic Transplants by Antagonizing Vasoactive Intestinal Peptide Signaling.Inflammation induces two types of inflammatory dendritic cells in inflamed lymph nodes.Understanding the Cellular Origin of the Mononuclear Phagocyte System Sheds Light on the Myeloid Postulate of Immune Paralysis in Sepsis.Establishment and Characterization of a Functionally Competent Type 2 Conventional Dendritic Cell Line
P2860
Q26781338-F60973C0-F8C5-4B1C-ABAF-E496F2029FC4Q27026193-42A064E8-9314-4646-93A2-2DF5B525F997Q28393754-174FF611-58D6-43F1-A21D-B4AD9816B321Q30849501-48FF260D-164A-4B3A-AEE3-313AB47FFF3FQ33659782-6AED4CBE-DD53-4D9A-B66C-20F389240BDEQ34226903-97885E69-2E87-432B-B4B3-FC09AB58DAD3Q35586004-602FD610-53B8-4BCA-9528-1EAF175722A1Q35908490-814E7782-8502-4CFE-89AC-BB235A2D9443Q36107961-9D45CDB7-B8CD-457B-A06B-7F1BEBF89DCBQ36736704-67903B3E-90A5-4DA8-9670-AED7C8F53BE1Q37086985-F19B9201-4A92-4439-B0A9-1584DCDAC13BQ37593675-512D5CD9-106C-447E-B579-5CBAB5A45E65Q37691850-8B6A3A4E-BABA-44F9-AE00-AA67F89929D2Q38166716-66E61B01-84B0-4513-BE48-4492DFC422AAQ38168787-370A3404-6FC2-41BC-89DD-152735D7744AQ38172131-97F7DC8F-B2B8-4F21-B3A0-7A2E0EF88D82Q38193807-26BCC754-D9DC-4736-925D-3E23D428FBBCQ38205437-1A31F2FF-CECB-4C5E-A4D8-592A158504D5Q38206571-15D7E05D-1CE6-4DB4-B7B4-7118AC24832CQ38206582-547D964A-C404-4848-ADDF-9B82B1028311Q38208305-499FADD3-B4DA-4A16-B373-D72A4F0997B0Q38821711-9606891B-18D8-4A0C-AA2B-4369E18F9085Q39104926-09901641-F362-47F4-9A24-D7EAAD03FC98Q39989398-D38CBB21-837B-4077-8983-DF9DFBB3FF1BQ40654151-876D7152-A641-48C3-8B82-6A54F7F33C60Q41155777-9436215B-E9F2-4B08-828F-9F42EDFCE737Q42558106-55D602FE-103B-4F2B-B0D0-4AF4A7446697Q47108315-EFE16D7A-BE2B-4CB7-90D9-A1CD41D3BCE9Q47139657-E84E1B30-56BA-47F3-B4B5-06F4CA08456FQ48974238-B5E2F4FF-E044-4A56-80F8-4E30AB6144A6Q51450182-FCB10166-C94F-432A-AB93-CBEBEEE6FF1AQ52652592-2309419F-5680-4008-BF32-D7DFF5C8A193Q54217613-F6E0F177-E891-4158-B7BA-9D90C7A2EE3FQ58705648-CBF414F6-D33A-48CC-AE90-B48BBC0AF5BD
P2860
Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?
@en
Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?
@nl
type
label
Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?
@en
Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?
@nl
prefLabel
Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?
@en
Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?
@nl
P2860
P356
P1433
P1476
Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?
@en
P2093
Edith Janssen
Gosse J Adema
P2860
P304
P356
10.1016/J.IT.2013.02.007
P577
2013-03-27T00:00:00Z